|
Rosuvastatin tert-Butyl Ester
|
瑞舒伐他汀叔丁酯
|
355806-00-7
|
|
Rosuvastatin Impurity 5
|
瑞舒伐他汀雜質(zhì)5
|
799842-07-2
|
|
Rosuvastatin Impurity 6
|
瑞舒伐他汀雜質(zhì)6
|
147118-35-2
|
|
Rosuvastatin Impurity 14
|
瑞舒伐他汀雜質(zhì)14
|
885477-83-8
|
|
Rosuvastatin Impurity 15
|
瑞舒伐他汀雜質(zhì)15
|
154026-95-6
|
|
Rupatadine Impurity 3 HCl
|
盧帕他定雜質(zhì)3鹽酸鹽
|
1007089-84-0
|
|
Levalbuterol HCl
|
左旋沙丁胺醇鹽酸鹽
|
50293-90-8
|
|
Sibutramine Impurity 2
|
西布曲明雜質(zhì)2
|
28049-61-8
|
|
Sildenafil Impurity 6
|
西地那非雜質(zhì)6
|
139756-02-8
|
|
Silodosin Impurity 4
|
西洛多辛雜質(zhì)4
|
160969-03-9
|
|
Simvastatin EP Impurity A Ammonium Salt
|
辛伐他汀EP雜質(zhì)A銨鹽
|
139893-43-9
|
|
Sitagliptin Phosphate
|
磷酸西他列汀
|
654671-78-0
|
|
Sitagliptin Impurity 13 HCl
|
西他列汀雜質(zhì)13鹽酸鹽
|
1204818-19-8
|
|
Sitagliptin Impurity 14
|
西他列汀雜質(zhì)14
|
922178-94-7
|
|
Sitagliptin Impurity 16
|
西他列汀雜質(zhì)16
|
762240-99-3
|
|
Sitagliptin Impurity 20 HCl
|
西他列汀雜質(zhì)20鹽酸鹽
|
762240-92-6
|
|
Sofosbuvir Impurity 7
|
索非布韋雜質(zhì)7
|
22224-41-5
|
|
Sulpiride EP Impurity D
|
舒必利EP雜質(zhì)D
|
22117-85-7
|
|
Sulpiride Impurity 3
|
舒必利雜質(zhì)3
|
22795-99-9
|
|
Tacrolimus
|
他克莫司
|
104987-11-3
|
|
Tadalafil Impurity 8
|
他達(dá)拉非雜質(zhì)8
|
14907-27-8
|
|
Telmisartan EP Impurity H
|
替米沙坦EP雜質(zhì)H
|
114772-40-6
|
|
Telmisartan Impurity 1
|
替米沙坦雜質(zhì)1
|
114772-38-2
|
|
Telmisartan Impurity 3
|
替米沙坦雜質(zhì)3
|
152628-01-8
|
|
Tenofovir Impurity 3 HCl
|
替諾福韋雜質(zhì)3鹽酸鹽
|
39613-92-8
|
|
Tenofovir Impurity 8
|
替諾福韋雜質(zhì)8
|
31618-90-3
|
|
Tenofovir Impurity 14
|
替諾福韋雜質(zhì)14
|
40510-81-4
|
|
Tenofovir Impurity 15
|
替諾福韋雜質(zhì)15
|
35179-98-7
|
|
Tenofovir Impurity 16
|
替諾福韋雜質(zhì)16
|
35180-01-9
|
|
(S)-Tenofovir
|
(S)-替諾福韋
|
147127-19-3
|
|
Terbutaline Impurity 1
|
特布他林雜質(zhì)1
|
26153-38-8
|
|
Terbutaline Impurity 4
|
特布他林雜質(zhì)4
|
22877-01-6
|
|
Thiamine Impurity 3
|
硫胺素雜質(zhì)3
|
13100-57-7
|
|
Ticagrelor EP Impurity D
|
替格瑞洛EP雜質(zhì)D
|
274693-26-4
|
|
Ticagrelor EP Impurity E
|
替格瑞洛EP雜質(zhì)E
|
376608-71-8
|
|
Ticagrelor Impurity 10 HCl
|
替格瑞洛雜質(zhì)10鹽酸鹽
|
1402222-66-5
|
|
Ticagrelor Impurity 13
|
替格瑞洛雜質(zhì)13
|
145783-14-8
|
|
Timolol EP Impurity D
|
噻嗎洛爾EP雜質(zhì)D
|
30165-97-0
|
|
Timolol EP Impurity F
|
噻嗎洛爾EP雜質(zhì)F
|
30165-96-9
|
|
Tiotropium Bromide Monohydrate
|
噻托溴銨一水合物
|
139404-48-1
|
|
Nicardipine EP Impurity C
|
尼卡地平EP雜質(zhì)C
|
21881-77-6
|
|
Ozagrel Impurity 4
|
奧扎格雷雜質(zhì)4
|
52188-06-4
|
|
Palbociclib Impurity 9
|
帕博西尼雜質(zhì)9
|
1651214-74-2
|
|
Palbociclib Impurity 14
|
帕博西尼雜質(zhì)14
|
1013916-37-4
|
|
Palbociclib Impurity 15
|
帕博西尼雜質(zhì)15
|
571188-59-5
|
|
Lenalidomide Impurity 7
|
來那度胺雜質(zhì)7
|
191732-70-4
|
|
Febuxostat Impurity 19
|
非布索坦雜質(zhì)19
|
34133-58-9
|
|
Erlotinib Impurity 20
|
厄洛替尼雜質(zhì)20
|
236750-65-5
|
|
Ramelteon Impurity 2
|
雷美替胺雜質(zhì)2
|
196597-78-1
|
|
Ramelteon Impurity 3
|
雷美替胺雜質(zhì)3
|
196597-79-2
|
|
Ramelteon Impurity 7
|
雷美替胺雜質(zhì)7
|
196597-17-8
|
|
Ramelteon Impurity 8
|
雷美替胺雜質(zhì)8
|
196597-77-0
|
|
Gefitinib EP Impurity A
|
吉非替尼EP雜質(zhì)A
|
199327-61-2
|
|
Oseltamivir Impurity 17
|
奧司他韋雜質(zhì)17
|
204254-96-6
|
|
Dabigatran Impurity 23 HCl
|
達(dá)比加群雜質(zhì)23鹽酸鹽
|
211914-50-0
|
|
Dabigatran Impurity 27
|
達(dá)比加群雜質(zhì)27
|
1642853-67-5
|
|
Enzalutamide Carboxylic Acid
|
恩雜魯胺羧酸
|
1242137-15-0
|
|
Apixaban Impurity 18
|
阿哌沙班雜質(zhì)18
|
27143-07-3
|
|
Apixaban Impurity 23
|
阿哌沙班雜質(zhì)23
|
27143-09-5
|
|
Apixaban Impurity 24
|
阿哌沙班雜質(zhì)24
|
1643330-62-4
|
|
Apixaban Impurity 25
|
阿哌沙班雜質(zhì)25
|
2098457-93-1
|
|
Ticagrelor Impurity 15 HCl
|
替格瑞洛雜質(zhì)15鹽酸鹽
|
1314324-00-9
|
|
Ticagrelor Impurity 18
|
替格瑞洛雜質(zhì)18
|
1616703-93-5
|
|
Ticagrelor Impurity 19
|
替格瑞洛雜質(zhì)19
|
1445580-43-7
|
|
Ticagrelor Impurity 26
|
替格瑞洛雜質(zhì)26
|
1823431-32-8
|
|
Canagliflozin Impurity 8
|
坎格列凈雜質(zhì)8
|
866607-35-4
|
|
Cabozantinib Impurity 16
|
卡博替尼雜質(zhì)16
|
748707-58-6
|
|
Olmesartan Impurity 14
|
奧美沙坦雜質(zhì)14
|
144690-92-6
|
|
Olmesartan Impurity 25
|
奧美沙坦雜質(zhì)25
|
144690-33-5
|
|
Olmesartan Impurity 27
|
奧美沙坦雜質(zhì)27
|
124750-51-2
|
|
Alogliptin Impurity 10
|
阿格列汀雜質(zhì)10
|
865758-95-8
|
|
Alogliptin Impurity 11
|
阿格列汀雜質(zhì)11
|
865758-96-9
|
|
Alogliptin Impurity 19
|
阿格列汀雜質(zhì)19
|
344957-25-1
|
|
Paliperidone USP Related Compound A
|
帕潘立酮USP雜質(zhì)A
|
849903-79-3
|
|
Paliperidone Impurity 3
|
帕潘立酮雜質(zhì)3
|
1008796-22-2
|
|
Sofosbuvir Impurity 15
|
索非布韋雜質(zhì)15
|
1334513-02-8
|
|
Azilsartan Impurity 16
|
阿齊沙坦雜質(zhì)16
|
1821386-21-3
|
|
Azilsartan Impurity 23
|
阿齊沙坦雜質(zhì)23
|
1696392-12-7
|
|
Azilsartan N-Hydroxy Methyl Ester
|
阿齊沙坦 N-羥基甲酯
|
147403-65-4
|
|
Sorafenib Impurity 7
|
索拉非尼雜質(zhì)7
|
2004659-84-9
|
|
Sorafenib Impurity 10
|
索拉非尼雜質(zhì)10
|
1431697-81-2
|
|
Argatroban Impurity 15
|
阿加曲班雜質(zhì)15
|
74892-82-3
|
|
Rac-7-Oxo-Pramipexole DiHCl
|
Rac-7-氧代-普拉克索二鹽酸
|
2245708-68-1
|
|
Clevidipine Impurity 5
|
氯維地平雜質(zhì)5
|
110962-94-2
|
|
Azacitidine Impurity 8
|
阿扎胞苷雜質(zhì)8
|
10302-78-0
|
|
Sitagliptin Impurity 24
|
西他列汀雜質(zhì)24
|
769195-26-8
|
|
Sitagliptin Impurity 27
|
西他列汀雜質(zhì)27
|
486459-98-7
|
|
Lurasidone Impurity 3 HCl
|
魯拉西酮雜質(zhì)3鹽酸鹽
|
87691-88-1
|
|
Tofacitinib Impurity 26 Dihydrochloride
|
托法替尼雜質(zhì)26二鹽酸鹽
|
1354486-07-9
|
|
Tofacitinib Impurity 29
|
托法替尼雜質(zhì)29
|
16372-08-0
|
|
LCZ-696 Impurity 17
|
沙庫巴曲纈沙坦雜質(zhì)17
|
1012341-54-6
|
|
Tofacitinib Impurity 36
|
托法替尼雜質(zhì)36
|
1616760-97-4
|
|
Oxcarbazepine EP Impurity C
|
奧卡西平EP雜質(zhì)C
|
21737-58-6
|
|
Olaparib Impurity 15
|
奧拉帕利雜質(zhì)15
|
16859-59-9
|
|
Salbutamol Impurity 9
|
沙丁胺醇雜質(zhì)9
|
41104-10-3
|
|
Tofacitinib Impurity 35
|
托法替尼雜質(zhì)35
|
1675248-18-6
|
|
LCZ-696 Impurity 19
|
沙庫巴曲纈沙坦雜質(zhì)19
|
1012341-52-4
|
|
Tofacitinib Impurity 30
|
托法替尼雜質(zhì)30
|
90213-66-4
|
|
Olaparib Impurity 16
|
奧拉帕利雜質(zhì)16
|
57260-71-6
|
|
Tofacitinib Impurity 5
|
托法替尼雜質(zhì)5
|
477600-70-7
|